$5750 | Single User
$11500 | Site License
$17250 | Enterprise License

Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025
[Report Updated: 31-07-2017]

Published by Delve Insight: 31 Jul 2017 | 116309 | In Stock

Introduction

DelveInsight’s “Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Vulvovaginal Candidiasis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Vulvovaginal Candidiasis . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Vulvovaginal Candidiasis for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Vulvovaginal Candidiasis market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Vulvovaginal Candidiasis , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Vulvovaginal Candidiasis for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Vulvovaginal Candidiasis 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Vulvovaginal Candidiasis market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

• Understanding historical and forecasted epidemiological data for Vulvovaginal Candidiasis covering 7MM from 2015-2025.

• Segment level epidemiology and market split for Vulvovaginal Candidiasis .

• The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Vulvovaginal Candidiasis .

• The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Vulvovaginal Candidiasis market trends.

• Thorough market distribution based on market share for Vulvovaginal Candidiasis .

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Vulvovaginal Candidiasis market.

• To understand the future market competition in the Vulvovaginal Candidiasis market and Insightful review of the key market drivers and barriers.

• Organize sales and marketing efforts by identifying the best opportunities for Vulvovaginal Candidiasis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

• Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Table of Contents
for Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 31-07-2017]

  • 1. Report Introduction

    2. Vulvovaginal Candidiasis Market Overview at a Glance

    2.1. Total Market Share Distribution of Vulvovaginal Candidiasis for 7 MM in 2016

    2.2. Total Market Share Distribution of Vulvovaginal Candidiasis for 7 MM in 2025

    3. Vulvovaginal Candidiasis

    3.1.1. Overview

    3.1.2. Symptoms

    3.1.3. Pathophysiology

    3.1.4. Staging

    3.1.5. Diagnosis

    3.1.6. Treatment

    4. Epidemiology and Patient Population

    4.1.1. United States

    4.1.1.1. Diagnosed Cases of Vulvovaginal Candidiasis in United States

    4.1.2. Germany

    4.1.2.1. Diagnosed Cases of Vulvovaginal Candidiasis in Germany

    4.1.3. France

    4.1.3.1. Diagnosed Cases of Vulvovaginal Candidiasis in France

    4.1.4. Italy

    4.1.4.1. Diagnosed Cases of Vulvovaginal Candidiasis in Italy

    4.1.5. Spain

    4.1.5.1. Diagnosed Cases of Vulvovaginal Candidiasis in Spain

    4.1.6. United Kingdom

    4.1.6.1. Diagnosed Cases of Vulvovaginal Candidiasis in United Kingdom

    5. Treatment Algorithm

    5.1.1. Treatment Guidelines/Practices

    6. Marketed Drugs for Vulvovaginal Candidiasis

    6.1. Drug 1: Company A

    6.1.1. Drug Description

    6.1.2. Mechanism of Action

    6.1.3. Regulatory Milestones

    6.1.4. Advantages & Disadvantages

    6.1.5. Safety and Efficacy

    6.1.6. Product Profile

    6.1.7. Patent Status

    6.2. Drug 2: Company B

    6.2.1. Drug Description

    6.2.2. Mechanism of Action

    6.2.3. Regulatory Milestones

    6.2.4. Advantages & Disadvantages

    6.2.5. Safety and Efficacy

    6.2.6. Product Profile

    6.2.7. Patent Status

    7. Emerging Therapies

    7.1. Drug 3: Company C

    7.1.1. Description

    7.1.2. Regulatory Milestones

    7.1.3. Advantages & Disadvantages

    7.1.4. Product Profile

    7.1.5. Launch Date

    7.1.6. Clinical Development

    7.1.7. Clinical Pipeline Activity

    7.1.8. Ongoing Trials Information

    7.1.9. Clinical Trial by Phase

    7.2. Drug 4: Company B

    7.2.1. Description

    7.2.2. Regulatory Milestones

    7.2.3. Advantages & Disadvantages

    7.2.4. Product Profile

    7.2.5. Launch Date

    7.2.6. Clinical Development

    7.2.7. Clinical Pipeline Activity

    7.2.8. Ongoing Trials Information

    7.2.9. Clinical Trial by Phase

    8. Overview of Total Vulvovaginal Candidiasis Market (2016 & 2025)

    9. Vulvovaginal Candidiasis : Country-Wise Market Analysis

    9.1. United States

    9.1.1. Historical Market Size (2015-2016)

    9.1.2. Forecasted Market Size (2017-2025)

    9.2. Germany Market Size

    9.2.1. Historical Market Size (2015-2016)

    9.2.2. Forecasted Market Size (2017-2025)

    9.3. France Market Size

    9.3.1. Historical Market Size (2015-2016)

    9.3.2. Forecasted Market Size (2017-2025)

    9.4. United Kingdom Market Size

    9.4.1. Historical Market Size (2015-2016)

    9.4.2. Forecasted Market Size (2017-2025)

    9.5. Spain Market Size

    9.5.1. Historical Market Size (2015-2016)

    9.5.2. Forecasted Market Size (2017-2025)

    9.6. Italy Market Size

    9.6.1. Historical Market Size (2015-2016)

    9.6.2. Forecasted Market Size (2017-2025)

    9.7. Japan Market Size

    9.7.1. Historical Market Size (2015-2016)

    9.7.2. Forecasted Market Size (2017-2025)

    10. Market Drivers

    11. Market Restraints

    12. Appendix

    13. Report Methodology

    14. Consulting Services

    15. Disclaimer

    16. About DelveInsight

List Of Tables
in Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 31-07-2017]

Table 1: Diagnosed Cases Vulvovaginal Candidiasis in United States (2015-2025)

Table 2: Diagnosed Cases Vulvovaginal Candidiasis in Germany (2015-2025)

Table 3: Diagnosed Cases Vulvovaginal Candidiasis in France (2015-2025)

Table 4: Diagnosed Cases Vulvovaginal Candidiasis in United Kingdom (2015-2025)

Table 5: Diagnosed Cases Vulvovaginal Candidiasis in Spain (2015-2025)

Table 6: Diagnosed Cases Vulvovaginal Candidiasis in Italy (2015-2025)

Table 7: Diagnosed Cases Vulvovaginal Candidiasis in Japan (2015-2025)

Table 8: List of Marketed Drugs for Vulvovaginal Candidiasis

Table 9: List of Pipeline Phase III Drugs for Vulvovaginal Candidiasis

Table 10: Drug 1, Clinical Trials by Zone, 2017

Table 11: Clinical Trials by Trial status, 2017

Table 12: Drug 2, Clinical Trials by Zone, 2017

Table 13: Clinical Trials by Trial status, 2017

Table 14: Drug 3, Clinical Trials by Zone, 2017

Table 15: Clinical Trials by Trial status, 2017

Table 16: United States Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Table 17: Germany Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Table 18: France Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Table 19: United Kingdom Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Table 20: Spain Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Table 21: Italy Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Table 22: Japan Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

List Of Figures, Charts and Diagrams
in Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 31-07-2017]

Figure 1: Diagnosed Cases Vulvovaginal Candidiasis in United States (2015-2025)

Figure 2: Diagnosed Cases Vulvovaginal Candidiasis in Germany (2015-2025)

Figure 3: Diagnosed Cases Vulvovaginal Candidiasis in France (2015-2025)

Figure 4: Diagnosed Cases Vulvovaginal Candidiasis in United Kingdom (2015-2025)

Figure 5: Diagnosed Cases Vulvovaginal Candidiasis in Spain (2015-2025)

Figure 6: Diagnosed Cases Vulvovaginal Candidiasis in Italy (2015-2025)

Figure 7: Diagnosed Cases Vulvovaginal Candidiasis in Japan (2015-2025)

Figure 8: List of Marketed Drugs for Vulvovaginal Candidiasis

Figure 9: List of Pipeline Phase III Drugs for Vulvovaginal Candidiasis

Figure 10: Drug 1, Clinical Trials by Zone (%), 2017

Figure 11: Clinical Trials by Trial status, 2017

Figure 12: Drug 2, Clinical Trials by Zone (%), 2017

Figure 13: Clinical Trials by Trial status, 2017

Figure 14: Drug 3, Clinical Trials by Zone (%), 2017

Figure 15: Clinical Trials by Trial status, 2017

Figure 16: United States Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Figure 17: Germany Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Figure 18: France Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Figure 19: United Kingdom Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Figure 20: Spain Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Figure 21: Italy Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Figure 22: Japan Market Size of Vulvovaginal Candidiasis in USD, Million (2015-2025)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

116309 | DIMI0237

Number of Pages

70

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025
DelveInsight’s “Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025...
31 Jul 2017 by Delve Insight USD $5,750 More Info
Vulvovaginal Candidiasis - Epidemiology Insights to 2025
DelveInsight’s “Vulvovaginal Candidiasis -Epidemiology Forecast, 2025” provides an overview of the e...
31 Jul 2017 by Delve Insight USD $2,950 More Info
Vulvovaginal Candidiasis - Pipeline Insight, 2017
DelveInsight’s, “ Vulvovaginal Candidiasis -Pipeline Insights, 2017”, report provides comprehensive ...
10 Jul 2017 by Delve Insight USD $1,250 More Info
Global Drugs for Vulvovaginal Candidiasis Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Drugs for Vulvovag...
29 Jun 2017 by S&P Consulting USD $2,800 More Info
Vulvovaginal Candidiasis-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,250 More Info
Vulvovaginal Candidiasis-Pipeline Insights, 2017
DelveInsight’s, “ Vulvovaginal Candidiasis-Pipeline Insights, 2017”, report provides in depth insigh...
30 May 2017 by Delve Insight USD $1,250 More Info
Vulvovaginal Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Vulvovaginal Candidiasis-Global API Manufacturers, Marketed and Phase III Dr...
30 May 2017 by Delve Insight USD $2,000 More Info
Global Drugs for Vulvovaginal Candidiasis Market Research Report Forecast 2017 to 2021
The Global Drugs for Vulvovaginal Candidiasis Market Research Report Forecast 2017-2021 is a valuabl...
27 Apr 2017 by S&P Consulting USD $2,800 More Info
Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2016
Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial r...
31 Aug 2016 by Global Data USD $2,500 More Info
Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2016
Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial r...
31 Aug 2016 by Global Data USD $2,500 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 31-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...